From Financial Modeling Prep: 2025-04-28 10:15:00

Cantor Fitzgerald lowers price target on Teradyne (NASDAQ:TER) from $110 to $90 due to a deteriorating macro environment and potential over-optimism for the rest of the year. Concerns raised about possible further revenue revisions for 2025, with EPS forecasted to fall to $2.50–$2.75 from the current consensus of $3.31.

Stock has already dropped 55% from 52-week highs, but Cantor sees more downside risk, possibly pushing shares to low-$60 range if earnings forecasts are cut further. Competitive pressures also a growing worry. Firm adjusts 2026 EPS expectations to $4.50, lower than management’s guidance of $5.50–$7.50.



Read more at Financial Modeling Prep:: Cantor Cuts Teradyne Price Target on Macro Worries…